Cloning in Farm Animals: Concepts and Applications
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Biotechnology and Society Syllabus
Nanyang Technological University Humanities and Social Sciences Semester 1, AY2017-2018 HH3010 Biotechnology and Society Syllabus Subject Description This subject will introduce students to selected research and commercial applications of modern biotechnology in order to discuss the broader social, ethical, risk, and regulatory issues that arise from them. A range of topics will be covered in this subject, including genetic engineering, cloning, stem cell research, the production of pharmaceuticals, the human genome project, genetic testing, assisted reproductive technologies, and synthetic biology. Students will consider debates that have taken place in the wider community about ownership, commercialisation, identity, governance, animal welfare, human well-being, and expertise in relation to these applications of modern biotechnology. Prerequisites: Nil Academic Units: 3 Teaching Staff Hallam Stevens Office: HSS-05-07 Email: [email protected] Attendance Requirements Students are expected to attend one two hour lecture and one one-hour tutorial once per week: Lectures: Wednesdays 12.30-2.30pm (LHS Lecture Theatre) Tutorials: Wednesdays 3.30pm-4.30pm OR 4.30pm-5.30pm OR 5.30-6.30pm (LHS TR+45) Tutorials begin in Week 2 and run through to Week 13 (except for weeks 7 and 9). You are required to attend at least eight of these tutorials. If you attend fewer than 8 tutorials you will get zero for your participation and discussion grade 1 (20% of your overall grade). This includes any excused absences (eg. medical reasons still count as “missed” tutorials). Medical certificates are not a get out of jail free card. Missing a seminar without an MC will mean an automatic zero for any attendance and participation marks awarded for that week. -
From Dolly to Zhong Zhong to Human Cloning?
Feature Article From Dolly to Zhong Zhong to Human Cloning? Zhong Zhong and Hua Hua (Photo courtesy: www.engadget.com) Biju Dharmapalan formal and ancient name for “China.” This scientific milestone has political HE recent news about the overtones. The name has been selected successful cloning of monkeys to show the Chinese supremacy in the by Chinese scientists grabbed scientific world, where most of the T dolly.roslin.ed.ac.uk) media attention some time back. In countries have put a blanket ban on a research paper published in the human cloning research. journal Cell (February 8, 2018), Public attention in cloning got Photo courtesy: scientists from the Chinese Academy significance with the birth of Dolly ( of Sciences in Shanghai announced the in 1996 by Sir Ian Wilmut’s group at successful cloning of a pair of Long- the Scottish Centre for Regenerative tailed macaques Zhong Zhong and Hua Medicine at the University of Edinburgh Dolly and her surrogate mother Hua using DNA from foetal connective through a technique known as Somatic tissue cells, using Somatic Cell Nuclear Cell Nuclear Transfer (SCNT). In then merges with the implanted nucleus Transfer (SCNT) technique, which was SCNT, the nucleus is removed from and develops into a clone of whatever it used to clone Dolly. an egg cell and is replaced with a was that donated the nucleus. The name Zhong Zhong was different nucleus from another cell, Dolly was cloned from a cell taken derived from the term Zhonghua, a usually a somatic cell. The egg cell from the mammary gland of a six-year- TIMELINE OF ANIMAL CLONING 1894: German biologist Hans Driesch used Xenopus laevis to show Schatten creates Tetra, a rhesus takes a two-cell sea urchin from that nuclei from specialised cells macaque, using embryo splitting the Bay of Naples and shakes still held the potential to be any technique. -
Edinburgh Research Explorer
Edinburgh Research Explorer Genetically engineering milk Citation for published version: Whitelaw, CBA, Joshi, A, Kumar, S, Lillico, SG & Proudfoot, C 2016, 'Genetically engineering milk', Journal of Dairy Research, vol. 83, no. 1, pp. 3-11. https://doi.org/10.1017/S0022029916000017 Digital Object Identifier (DOI): 10.1017/S0022029916000017 Link: Link to publication record in Edinburgh Research Explorer Document Version: Peer reviewed version Published In: Journal of Dairy Research General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 25. Sep. 2021 Short title: Genetically engineering milk Genetically engineering milk C. Bruce A. Whitelaw1,*, Akshay Joshi1, Satish Kumar2, Simon G. Lillico1 and Chris Proudfoot1. The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Easter Bush CamPus, Midlothian EH25 9RG, UK1 Centre for Cellular and Molecular Biology, Hyderabad, India2 * For correspondence: [email protected] Received 22nd December 2015 and accepted for Publication 1st January 2016 It has been thirty years since the first genetically engineered animal with altered milk composition was rePorted. -
Transgenic Animals
IQP-43-DSA-4330 IQP-43-DSA-0486 TRANSGENIC ANIMALS An Interactive Qualifying Project Report Submitted to the Faculty of WORCESTER POLYTECHNIC INSTITUTE In partial fulfillment of the requirements for the Degree of Bachelor of Science By: ____________________ ____________________ Travis Abele Michelle Miller August 27, 2008 APPROVED: _________________________ Prof. David S. Adams, Ph.D. WPI Project Advisor ABSTRACT This project examined the methods of creating transgenic animals, the reasons for doing so, and the effect of this controversial new technology on society via ethical and legal issues. A detailed description of what a transgenic animal is, how they are created, and their use in society today and in the future was followed by how transgenic animals have already provided much societal benefit, including information on human diseases, drugs to save human lives, and knowledge of the biological function of newly discovered proteins. Transgenic technology should have a positive impact on society as long as animal suffering is kept at a minimum and used solely for the purpose of helping humans. 2 TABLE OF CONTENTS Signature Page …………………………………………………………………….. 1 Abstract ……………………………………………………………………………. 2 Table of Contents ………………………………………………………………….. 3 Project Objective ……………………………………...…………………………… 4 Chapter-1: Transgenic Technology …….………………………………………… 5 Chapter-2: Transgenic Applications ..…………………………………………….. 20 Chapter-3: Transgenic Ethics …………………………………………………… 35 Chapter-4: Transgenic Legalities …………………………………………………. 47 Conclusions ………………………………………………………………………… 59 3 PROJECT OBJECTIVES The objective of this IQP project was to examine the topic of transgenic animals and to discuss the effect of this controversial new technology on society. The report explains to readers what transgenic animals are, how they are created, and describes the types of transgenic animals created to date. -
Asymmetric Nuclear Reprogramming in Somatic Cell Nuclear Transfer? Pasqualino Loi, Nathalie Beaujean, Saadi Khochbin, Josef Fulka, Grazyna Ptak
Asymmetric nuclear reprogramming in somatic cell nuclear transfer? Pasqualino Loi, Nathalie Beaujean, Saadi Khochbin, Josef Fulka, Grazyna Ptak To cite this version: Pasqualino Loi, Nathalie Beaujean, Saadi Khochbin, Josef Fulka, Grazyna Ptak. Asymmetric nuclear reprogramming in somatic cell nuclear transfer?. BioEssays, Wiley-VCH Verlag, 2008, 30 (1), pp.66- 74. 10.1002/bies.20684. hal-02610575 HAL Id: hal-02610575 https://hal.archives-ouvertes.fr/hal-02610575 Submitted on 17 May 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Asymmetric nuclear reprogramming in somatic cell nuclear transfer? Pasqualino Loi1* Nathalie Beaujean2 Saadi Khochbin3,4 Josef Fulka Jr.5 and Grazyna Ptak1 1Department of Comparative Biomedical Sciences, Teramo, Italy. 2Biologie du De´veloppement et Reproduction, INRA, Jouy-en-Josas, France. 3INSERM, U823, Institut Albert Bonniot, Epigenetic and Cell Signalling Team, Grenoble, France. 4Universite´ Joseph Fourier, Grenoble, France. 5Institute of Animal Sciences, Prague, Czech Republic Funding agency: Research in PL and GP laboratories is founded by the European Science Foundation EUROCORES Programme Euro-STELLS, contract no. ERAS-CT-2003-980409 and PRIN 2006. S.K. laboratory is supported by grants from the Regulome Consortium (ANR-05-BLAN-0396-04), the CLARA (EpiPro program) and ARECA (ARC) programmes. -
(Macaca Fascicularis) Embryos with ICSI Based on the MII-Stage
bioRxiv preprint doi: https://doi.org/10.1101/475897; this version posted November 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Generation of Cynomolgus Monkeys (Macaca fascicularis) Embryos with ICSI Based on the MII-Stage Oocytes Acquired by Personalized Superovulation Protocol Zhangqiong Huang1,2,3 #, Yun Li1,2,3#, Qinfang Jiang1,2,3 , Yixuan Wang1,2,3, Kaili Ma 1,2,3§ and Qihan Li1,2§ 1 Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 935, Jiaoling Road, Kunming 2 Medical Primate Research Center & Neuroscience Center, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 935, Jiaoling Road, Kunming 3 Yunnan Key Laboratory of Vaccine Research Development on Severe Infectious Diseases, No. 935, Jiaoling Road, Kunming # Zhangqiong Huang and Yun Li contributed equally to this work §Author for correspondence ([email protected] and [email protected]) KEYWORDS: cynomolgus monkeys, MII-stage oocyte, personalized superovulation, embryos, menstrual cycles, sexual swelling, stigma of ovary SUMMARY STATEMENT The personalized superovulation protocol based on the menstrual cycle length of each cynomolgus monkey can increase the rate of MII-stage oocytes acquired, and finally could successfully develop into fetus under conditions that minimize damage to the surrogate mothers and effectively guarantee the synchronization of the surrogate mothers. ABSTRACT The use of cynomolgus monkeys (Macaca fascicularis) has facilitated the 1 bioRxiv preprint doi: https://doi.org/10.1101/475897; this version posted November 25, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. -
Reproductive Biology and Endocrinology
View metadata, citation and similar papers at core.ac.uk brought to you by CORE Reproductive Biology and provided by PubMed Central Endocrinology BioMed Central Review Open Access Strategies for the production of genetically identical monkeys by embryo splitting RD Schramm* and AM Paprocki Address: Wisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin 53715, USA Email: RD Schramm* - [email protected]; AM Paprocki - [email protected] * Corresponding author Published: 16 June 2004 Received: 23 February 2004 Accepted: 16 June 2004 Reproductive Biology and Endocrinology 2004, 2:38 This article is available from: http://www.rbej.com/content/2/1/38 © 2004 Schramm and Paprocki; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permit- ted in all media for any purpose, provided this notice is preserved along with the article's original URL. Abstract Genetically identical rhesus monkeys would have tremendous utility as models for the study of human disease and would be particularly valuable for vaccine trials and tissue transplantation studies where immune function is important. While advances in nuclear transfer technology may someday enable monkeys to be cloned with some efficiency, embryo splitting may be a more realistic approach to creating pairs of genetically identical monkeys. Although several different approaches to embryo splitting, including blastocyst bisection and blastomere separation, have been used successfully in rodents and domestic species for production of pairs and sets of identical offspring, efforts to create monozygotic twins in rhesus monkeys using these approaches have not met with similar success. Aggregation of split embryos with other types of blastomeres, such as tetraploid and developmentally asynchronous blastomeres, that could potentially increase their cell numbers and developmental competence without contributing to term development has been investigated as an alternative approach to creating monozygotic twin monkeys. -
Artificial Cloning of Domestic Animals
Artificial cloning of domestic animals Carol L. Keefer1 Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742 Edited by Francisco J. Ayala, University of California, Irvine, CA, and approved April 15, 2015 (received for review February 6, 2015) Domestic animals can be cloned using techniques such as embryo the blastomeres of an early embryo and forming two or more splitting and nuclear transfer to produce genetically identical smaller embryos. Initial studies were performed to ask key individuals. Although embryo splitting is limited to the production questions regarding control of lineage development: When is a of only a few identical individuals, nuclear transfer of donor nuclei cell’s fate set and how plastic is that fate? Studies in amphibians, into recipient oocytes, whose own nuclear DNA has been removed, rabbits, and mice suggested that the very early cleavage stages can result in large numbers of identical individuals. Moreover, (two-cell to four-cell) were flexible and that each blastomere clones can be produced using donor cells from sterile animals, such could yield a viable blastocyst. At later stages, the blastomeres as steers and geldings, and, unlike their genetic source, these clones could no longer independently form a viable blastocyst due to the are fertile. In reality, due to low efficiencies and the high costs of loss of mass as each blastomere underwent cleavage division. cloning domestic species, only a limited number of identical in- That did not mean that the blastomere nucleus was incapable dividuals are generally produced, and these clones are primarily of directing full development, but rather that it was unable to used as breed stock. -
Transcriptional Defects and Reprogramming Barriers in Somatic
Liu et al. BMC Genomics (2018) 19:734 https://doi.org/10.1186/s12864-018-5091-1 RESEARCH ARTICLE Open Access Transcriptional defects and reprogramming barriers in somatic cell nuclear reprogramming as revealed by single- embryo RNA sequencing Yong Liu1† , Fengrui Wu1†, Ling Zhang1, Xiaoqing Wu1, Dengkun Li1, Jing Xin1, Juan Xie1, Feng Kong1, Wenying Wang1, Qiaoqin Wu1, Di Zhang1, Rong Wang1, Shaorong Gao2 and Wenyong Li1* Abstract Background: Nuclear reprogramming reinstates totipotency or pluripotency in somatic cells by changing their gene transcription profile. This technology is widely used in medicine, animal husbandry and other industries. However, certain deficiencies severely restrict the applications of this technology. Results: Using single-embryo RNA-seq, our study provides complete transcriptome blueprints of embryos generated by cumulus cell (CC) donor nuclear transfer (NT), embryos generated by mouse embryonic fibroblast (MEF) donor NT and in vivo embryos at each stage (zygote, 2-cell, 4-cell, 8-cell, morula, and blastocyst). According to the results from further analyses, NT embryos exhibit RNA processing and translation initiation defects during the zygotic genome activation (ZGA) period, and protein kinase activity and protein phosphorylation are defective during blastocyst formation. Two thousand three constant genes are not able to be reprogrammed in CCs and MEFs. Among these constant genes, 136 genes are continuously mis-transcribed throughout all developmental stages. These 136 differential genes may be reprogramming barrier genes (RBGs) and more studies are needed to identify. Conclusions: These embryonic transcriptome blueprints provide new data for further mechanistic studies of somatic nuclear reprogramming. These findings may improve the efficiency of somatic cell nuclear transfer. -
Human Embryonic Stem Cells and Clinical Applications
Cell Research (2008) 18:s171. npg © 2008 IBCB, SIBS, CAS All rights reserved 1001-0602/08 $ 30.00 Plenary Session 5 www.nature.com/cr Human embryonic stem cells and clinical applications Alan Colman1 1 Executive Director, Singapore Stem Cell Consortium, A*STAR Institute of Medical Biology, Singapore With the 2007 Nobel prize awards to Evans, Capecchi and Smithers, embryonic stem cell research has been rightly recognized for its enormous contributions towards increasing our understanding of mammalian development and disease. Much of this insight has arisen from the provision of mice knock out models. However, observations that the embryonic stem cell can be coaxed into a multitude of different cell types in vitro have also captured enormous attention. This matchless versatility is now being intensively exploited in human embryonic stem cells (hESC) with a view to providing partial or complete cures for a vast legion of troubling human ailments. Whilst the pluripotential nature of hESC offers the advantage, in principle, of allowing a wide choice of disease targets, the early developmental status of the cells makes efficient and correct differentiation into the desired adult cell types a difficult undertaking. In my lecture, I will explore the challenges and progress that accompany the translational efforts being made with hESC. In particular, I will survey progress towards clinical applications in the diabetes, congestive heart failure and spinal injury indications, paying attention to outstanding regulatory issues like safety and GMP compliance in this very difficult area of cell therapy. I will conclude that technical difficulties together with regulatory and investment concerns, are likely to impede clinical development of hESC cell therapy. -
CIRM - MRC Human Somatic Cell Nuclear Transfer Workshop Report
CIRM - MRC Human Somatic Cell Nuclear Transfer Workshop Report June 13-14, 2010 HUMAN SCNT WORKSHOP REPORT CHAPTER 1. EXECUTIVE SUMMARY Somatic cell nuclear transfer (SCNT), or nuclear reprogramming achieved through transplantation of a somatic cell nucleus into the cytoplasm of an egg, has led to breakthroughs in our understanding of cellular reprogramming and other normal developmental processes. While SCNT was first developed in the 1950s and 60s using frogs (Gurdon, 1962a, 1962b, 1962c) and then successfully applied to mammals in 1996 (Campbell, et al., 1996), the therapeutic possibilities of this technology were not appreciated until after the derivation of the first embryonic stem cells from mouse SCNT embryos (Munsie, et al., 2000), and the availability of human embryonic stem cells (hESC) (Thomson, et al., 1998). These developments led to a new paradigm in regenerative medicine, the idea of creating self-renewing pluripotent stem cell lines which contained an exact copy of a patient’s own nuclear genetic material. In spite of this promising beginning, human SCNT (hSCNT) remains challenging and it has not yet led to the production of any pluripotent stem cell lines. Meanwhile, increased understanding of the molecular mechanisms that govern cell fate has led to recent breakthroughs in our ability to reprogram human somatic cells by other methods, such as generation of induced pluripotent stem cells (iPSCs) by forced expression of transcription factors (Takahashi, et al., 2007; Takahashi & Yamanaka, 2006; J. Yu, et al., 2007). Thus, the role of hSCNT in a new world of factor-mediated reprogramming needs to be reexamined in light of the significant technical and ethical challenges facing the field. -
Biotechnology Explorer™
araC ori pGLO GFP bla Biotechnology Explorer™ pGLO™ Bacterial Transformation Kit Catalog #166-0003EDU explorer.bio-rad.com See individual components for storage temperature. Duplication of any part of this document is permitted for classroom use only. Please visit explorer.bio-rad.com to access our selection of language translations for Biotechnology Explorer kit curricula. For technical support call your local Bio-Rad office, or in the U.S., call 1-800-424-6723 How can jellyfish shed light on the subject? One of the biggest challenges for first-time students of biotechnology or molecular biology is that many of the events and processes they are studying are invisible. The Biotechnology Explorer program has a solution: a gene from a bioluminescent jellyfish and its Green Fluorescent Protein—GFP. GFP fluoresces a brilliant green when viewed with a hand-held long-wave ultraviolet light (such as a pocket geology lamp). The gene for GFP was originally isolated from the jellyfish, Aequorea victoria. The wild-type jellyfish gene has been modified by Maxygen Inc., a biotechnology company in Santa Clara, California. Specific mutations were introduced into the DNA sequence, which greatly enhance fluorescence of the protein. This modified form of the GFP gene has been inserted into Bio-Rad’s pGLO plasmid and is now available exclusively from Bio-Rad for educational applications. GFP is incredibly bright. Using pGLO to transform bac teria, students can actually observe gene expression in real time. Following the transformation with Bio-Rad’s GFP purification kit, students purify the genetically engineered GFP from their transformed bacteria using a simple chromatography procedure.